(19)
(11) EP 4 816 360 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898531.9

(22) Date of filing: 21.11.2024
(51) International Patent Classification (IPC): 
C07D 309/10(2006.01)
A61P 35/00(2006.01)
A61K 31/7028(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7028; A61P 35/00; A61K 45/06; C07K 16/2803; C07K 16/32; A61K 2039/507; A61K 39/39558; C07H 15/04; A61K 31/7056; A61K 47/55; A61K 47/549
 
C-Sets:
  1. A61K 39/39558, A61K 2300/00;
  2. A61K 31/7056, A61K 2300/00;

(86) International application number:
PCT/US2024/056790
(87) International publication number:
WO 2025/117308 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 US 202363603675 P
12.01.2024 US 202463620199 P
09.10.2024 US 202463705103 P

(71) Applicant: The Scripps Research Institute
La Jolla, CA 92037 (US)

(72) Inventors:
  • WU, Peng
    San Diego, CA 92122 (US)
  • WANG, Chao
    Palm Beach Garden, FL 33418 (US)

(74) Representative: Hutter, Anton 
Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park
Guildford GU2 7RF
Guildford GU2 7RF (GB)

   


(54) HIGH-AFFINITY SIGLEC-7/9 LIGANDS FOR CANCER IMMUNOTHERAPY